SOLV today
$88.62-$1.46 (-1.62%)close Nov 11, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourAscending Triangle
15 minSymmetric Triangle
5 minConsolidating
Daily trend turns up above $94.16
Key levels
Resistance$91.87
Support$87.87
Support$84.00
Latest news & SEC filings
DealAhlstrom and Solventum team up on release paper with controlled bioburden
AnalystWells Fargo keeps Equal-Weight on Solventum, lifts target to $95
AnalystPiper Sandler keeps Overweight on Solventum, lifts target to $110
All SOLV news →About Solventum
Solventum is a global healthcare company that develops, manufactures, and sells medical, dental, and health information technology products. Its MedSurg segment offers wound care, sterilization, surgical supplies, and medical tapes; Dental Solutions provides orthodontic and restorative dental products; and Health Information Systems supplies clinical documentation, coding, and revenue cycle software. Customers include hospitals, clinics, dental practices, and healthcare systems, served in more than 90 countries.
Based on the company's 10-K filed Feb 27, 2026.
NYSE · Healthcare
Solventum Corp (SOLV)
What Is the Price Target for SOLV?
SEPT Low Target
$70.00
SEPT Mid Target
$101.00
SEPT High Target
$110.00
Analyst Consensus
$101.00
Is SOLV a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.9% YoY with SLOWING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SOLV.
Start Free Trial →Is SOLV Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$106.34
51
Moat Score
NARROW
6/9
Piotroski Score
2.3
Altman Z-Score
What Is Smart Money Doing with SOLV?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
BUYING
2 buys / 1 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SOLV Growth Story
Revenue YoY
0.9%
3yr Revenue CAGR
0.8%
EPS Growth YoY
221.74%
FCF Growth YoY
-101.2%
Revenue Trend
SLOWING
Dark Pool Trades for SOLV
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SOLV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:28:26 | $88.62 | 2,268 | $$201K | BUY |
| 21:00:32 | $88.62 | 1,043 | $$92K | BUY |
| 21:00:31 | $88.62 | 3,041 | $$269K | BUY |
| 21:00:31 | $88.62 | 2,192 | $$194K | BUY |
| 21:00:12 | $88.62 | 4,856 | $$430K | BUY |
5 dark pool trades shown · $$1.2M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Solventum Corp (SOLV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SOLV — frequently asked questions
What is SOLV stock price today?
Solventum Corp (SOLV) is at $88.62, down 1.62% (-$1.46) at the Nov 11, 2026 close.
Why is SOLV stock moving today?
Latest SOLV news — Nov 9, 2026: Ahlstrom and Solventum team up on release paper with controlled bioburden · Nov 6, 2026: Wells Fargo keeps Equal-Weight on Solventum, lifts target to $95
What is the SOLV price target?
The average analyst price target for SOLV is $101.00, ranging from $70 to $110, based on 9 analysts.
What do analysts rate SOLV?
Analyst ratings for SOLV: 2 Buy, 13 Hold, 0 Sell — consensus Hold.
Did SOLV beat earnings?
SOLV last reported on Nov 5, 2026: EPS $1.45 vs $1.34 expected — a beat of 8.2%.
What is SOLV's P/E ratio?
SOLV trades at a P/E of 10.6 vs a Healthcare average of 17.7.
Does SOLV pay a dividend?
SOLV does not currently pay a dividend.
What are SOLV support and resistance levels?
Support: $87.87, $84.00, $80.76. Resistance: $91.87.
What are insiders doing with SOLV?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on SOLV?
Nov 9, 2026: Ahlstrom and Solventum team up on release paper with controlled bioburden · Nov 6, 2026: Wells Fargo keeps Equal-Weight on Solventum, lifts target to $95 · Nov 6, 2026: Piper Sandler keeps Overweight on Solventum, lifts target to $110